Stroke:可逆性脑血管收缩综合征,有何临床特点?

2021-09-07 Freeman MedSci原创

以整个美国人口推算,每年有>1000名RCVS患者住院,其中大多数是中年妇女

近年来,可逆性脑血管收缩综合征(RCVS)已被越来越多的人认识。来自美国、亚洲和欧洲的系列报道共描述了900名患者。RCVS可表现为许多症状和并发症,从没有脑部病变的孤立的严重头痛,到罕见的有多处中风的严重形式。该病在女性和中年人中最常见。

美国缺乏关于RCVS住院频率、病人和医院层面特征的当代数据。从以往的病例系列来看,短期疗效大多很好,但RCVS可导致严重残疾,在美国的两个系列中,死亡率达到2%至7%。

不良的结果与缺血性和出血性中风有关。在RCVS的并发症中存在着人群间的差异,这可能是由于个别病例系列中的患者数量有限,以及从不同环境(头痛诊所和住院病人)收集的患者的异质性。


为了解决这一知识空白,美国康涅狄格大学的 Smit D. Patel等人使用了美国最大的全国住院病人数据库来确定RCVS的频率、特征和与短期结果相关的因素。

他们分析了美国全国住院病人样本数据库(2016-2017),以描述RCVS的住院频率、人口统计学特征、住院病人死亡率和出院结果。

在2年的研究期间,全国范围内的住院样本医院共收治了2020名RCVS患者,占全国每10万次住院的0.02例。入院时的平均年龄为47.6岁,85%在65岁以下,75.5%为女性。

住院期间合并的神经系统诊断包括缺血性中风(17.1%)、脑内出血(11.0%)、蛛网膜下腔出血(32.7%)、癫痫症(6.7%)和可逆性脑水肿(13.6%)。

总体而言,70%的患者出院回家,29.7%的患者出院到康复机构或疗养院,0.3%的患者在出院前死亡。与出院到其他机构或死亡的不良结果独立相关的患者特征是高龄(几率比[OR],1.04[95% CI,1.03-1.04])、女性(OR,2.45[1.82-3.34])、脑内出血(OR,2。 91 [1.96-4.31]),缺血性中风(OR,5.72 [4.32-7.58]),癫痫病(OR,2.61 [1.70-4.00]),可逆性脑水肿(OR,6.26 [4.41-8.89]),心房颤动(OR,2.97 [1.83-4.81]),和慢性肾病(OR,3.43 [2.19-5.36])。

这个研究的重要意义在于发现了:以整个美国人口推算,每年有>1000名RCVS患者住院,其中大多数是中年妇女,约有300人出院后至少需要一些康复或疗养院护理。与RCVS相关的住院病人死亡率很少。


原文出处:
Patel SD, Topiwala K, Otite Oliver F, et al. Outcomes Among Patients With Reversible Cerebral Vasoconstriction Syndrome: A Nationwide United States Analysis. Stroke. Published online September 2, 2021. doi:10.1161/STROKEAHA.121.034424

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1933896, encodeId=87a61933896ee, content=<a href='/topic/show?id=7c1c2288877' target=_blank style='color:#2F92EE;'>#临床特点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22888, encryptionId=7c1c2288877, topicName=临床特点)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3679417, createdName=feather78, createdTime=Wed Apr 27 11:58:45 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1950652, encodeId=43ae195065257, content=<a href='/topic/show?id=e3928966841' target=_blank style='color:#2F92EE;'>#血管收缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89668, encryptionId=e3928966841, topicName=血管收缩)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b30126, createdName=skhzy, createdTime=Tue Nov 16 02:58:45 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1935819, encodeId=63cd1935819b3, content=<a href='/topic/show?id=aa93385331c' target=_blank style='color:#2F92EE;'>#可逆性脑血管收缩综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38533, encryptionId=aa93385331c, topicName=可逆性脑血管收缩综合征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85152500072, createdName=124987c6m36暂无昵称, createdTime=Sat Jan 01 05:58:45 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1432138, encodeId=36471432138d6, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Sep 09 20:58:45 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1580258, encodeId=cfb2158025849, content=<a href='/topic/show?id=76743853197' target=_blank style='color:#2F92EE;'>#可逆性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38531, encryptionId=76743853197, topicName=可逆性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=023016601943, createdName=小华子, createdTime=Thu Sep 09 20:58:45 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015900, encodeId=d1bc101590020, content=新的理论,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df324723890, createdName=452946589, createdTime=Wed Sep 08 23:32:39 CST 2021, time=2021-09-08, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1933896, encodeId=87a61933896ee, content=<a href='/topic/show?id=7c1c2288877' target=_blank style='color:#2F92EE;'>#临床特点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22888, encryptionId=7c1c2288877, topicName=临床特点)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3679417, createdName=feather78, createdTime=Wed Apr 27 11:58:45 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1950652, encodeId=43ae195065257, content=<a href='/topic/show?id=e3928966841' target=_blank style='color:#2F92EE;'>#血管收缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89668, encryptionId=e3928966841, topicName=血管收缩)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b30126, createdName=skhzy, createdTime=Tue Nov 16 02:58:45 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1935819, encodeId=63cd1935819b3, content=<a href='/topic/show?id=aa93385331c' target=_blank style='color:#2F92EE;'>#可逆性脑血管收缩综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38533, encryptionId=aa93385331c, topicName=可逆性脑血管收缩综合征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85152500072, createdName=124987c6m36暂无昵称, createdTime=Sat Jan 01 05:58:45 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1432138, encodeId=36471432138d6, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Sep 09 20:58:45 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1580258, encodeId=cfb2158025849, content=<a href='/topic/show?id=76743853197' target=_blank style='color:#2F92EE;'>#可逆性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38531, encryptionId=76743853197, topicName=可逆性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=023016601943, createdName=小华子, createdTime=Thu Sep 09 20:58:45 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015900, encodeId=d1bc101590020, content=新的理论,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df324723890, createdName=452946589, createdTime=Wed Sep 08 23:32:39 CST 2021, time=2021-09-08, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1933896, encodeId=87a61933896ee, content=<a href='/topic/show?id=7c1c2288877' target=_blank style='color:#2F92EE;'>#临床特点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22888, encryptionId=7c1c2288877, topicName=临床特点)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3679417, createdName=feather78, createdTime=Wed Apr 27 11:58:45 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1950652, encodeId=43ae195065257, content=<a href='/topic/show?id=e3928966841' target=_blank style='color:#2F92EE;'>#血管收缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89668, encryptionId=e3928966841, topicName=血管收缩)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b30126, createdName=skhzy, createdTime=Tue Nov 16 02:58:45 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1935819, encodeId=63cd1935819b3, content=<a href='/topic/show?id=aa93385331c' target=_blank style='color:#2F92EE;'>#可逆性脑血管收缩综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38533, encryptionId=aa93385331c, topicName=可逆性脑血管收缩综合征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85152500072, createdName=124987c6m36暂无昵称, createdTime=Sat Jan 01 05:58:45 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1432138, encodeId=36471432138d6, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Sep 09 20:58:45 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1580258, encodeId=cfb2158025849, content=<a href='/topic/show?id=76743853197' target=_blank style='color:#2F92EE;'>#可逆性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38531, encryptionId=76743853197, topicName=可逆性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=023016601943, createdName=小华子, createdTime=Thu Sep 09 20:58:45 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015900, encodeId=d1bc101590020, content=新的理论,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df324723890, createdName=452946589, createdTime=Wed Sep 08 23:32:39 CST 2021, time=2021-09-08, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1933896, encodeId=87a61933896ee, content=<a href='/topic/show?id=7c1c2288877' target=_blank style='color:#2F92EE;'>#临床特点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22888, encryptionId=7c1c2288877, topicName=临床特点)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3679417, createdName=feather78, createdTime=Wed Apr 27 11:58:45 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1950652, encodeId=43ae195065257, content=<a href='/topic/show?id=e3928966841' target=_blank style='color:#2F92EE;'>#血管收缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89668, encryptionId=e3928966841, topicName=血管收缩)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b30126, createdName=skhzy, createdTime=Tue Nov 16 02:58:45 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1935819, encodeId=63cd1935819b3, content=<a href='/topic/show?id=aa93385331c' target=_blank style='color:#2F92EE;'>#可逆性脑血管收缩综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38533, encryptionId=aa93385331c, topicName=可逆性脑血管收缩综合征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85152500072, createdName=124987c6m36暂无昵称, createdTime=Sat Jan 01 05:58:45 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1432138, encodeId=36471432138d6, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Sep 09 20:58:45 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1580258, encodeId=cfb2158025849, content=<a href='/topic/show?id=76743853197' target=_blank style='color:#2F92EE;'>#可逆性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38531, encryptionId=76743853197, topicName=可逆性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=023016601943, createdName=小华子, createdTime=Thu Sep 09 20:58:45 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015900, encodeId=d1bc101590020, content=新的理论,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df324723890, createdName=452946589, createdTime=Wed Sep 08 23:32:39 CST 2021, time=2021-09-08, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1933896, encodeId=87a61933896ee, content=<a href='/topic/show?id=7c1c2288877' target=_blank style='color:#2F92EE;'>#临床特点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22888, encryptionId=7c1c2288877, topicName=临床特点)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3679417, createdName=feather78, createdTime=Wed Apr 27 11:58:45 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1950652, encodeId=43ae195065257, content=<a href='/topic/show?id=e3928966841' target=_blank style='color:#2F92EE;'>#血管收缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89668, encryptionId=e3928966841, topicName=血管收缩)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b30126, createdName=skhzy, createdTime=Tue Nov 16 02:58:45 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1935819, encodeId=63cd1935819b3, content=<a href='/topic/show?id=aa93385331c' target=_blank style='color:#2F92EE;'>#可逆性脑血管收缩综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38533, encryptionId=aa93385331c, topicName=可逆性脑血管收缩综合征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85152500072, createdName=124987c6m36暂无昵称, createdTime=Sat Jan 01 05:58:45 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1432138, encodeId=36471432138d6, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Sep 09 20:58:45 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1580258, encodeId=cfb2158025849, content=<a href='/topic/show?id=76743853197' target=_blank style='color:#2F92EE;'>#可逆性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38531, encryptionId=76743853197, topicName=可逆性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=023016601943, createdName=小华子, createdTime=Thu Sep 09 20:58:45 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015900, encodeId=d1bc101590020, content=新的理论,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df324723890, createdName=452946589, createdTime=Wed Sep 08 23:32:39 CST 2021, time=2021-09-08, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1933896, encodeId=87a61933896ee, content=<a href='/topic/show?id=7c1c2288877' target=_blank style='color:#2F92EE;'>#临床特点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22888, encryptionId=7c1c2288877, topicName=临床特点)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3679417, createdName=feather78, createdTime=Wed Apr 27 11:58:45 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1950652, encodeId=43ae195065257, content=<a href='/topic/show?id=e3928966841' target=_blank style='color:#2F92EE;'>#血管收缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89668, encryptionId=e3928966841, topicName=血管收缩)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b30126, createdName=skhzy, createdTime=Tue Nov 16 02:58:45 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1935819, encodeId=63cd1935819b3, content=<a href='/topic/show?id=aa93385331c' target=_blank style='color:#2F92EE;'>#可逆性脑血管收缩综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38533, encryptionId=aa93385331c, topicName=可逆性脑血管收缩综合征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85152500072, createdName=124987c6m36暂无昵称, createdTime=Sat Jan 01 05:58:45 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1432138, encodeId=36471432138d6, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Sep 09 20:58:45 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1580258, encodeId=cfb2158025849, content=<a href='/topic/show?id=76743853197' target=_blank style='color:#2F92EE;'>#可逆性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38531, encryptionId=76743853197, topicName=可逆性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=023016601943, createdName=小华子, createdTime=Thu Sep 09 20:58:45 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015900, encodeId=d1bc101590020, content=新的理论,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df324723890, createdName=452946589, createdTime=Wed Sep 08 23:32:39 CST 2021, time=2021-09-08, status=1, ipAttribution=)]
    2021-09-08 452946589

    新的理论,学习了

    0

相关资讯

Stroke:脑中风后,患者的长期生活功能如何变化?

在脑卒中后的慢性阶段,功能限制首先趋于平稳,然后增加,其演变因残疾的严重程度而异

JAMA子刊:卒中急救成绩卓然——不同卒中中心在卒中患者分流情况对比

实施综合卒中中心分流的院前转运政策与AIS患者EVT率的显著、快速和持续增加有关

JAMA Neurology:脑卒中后,使用氟西汀是否能有效缓解抑郁症状?

与安慰剂相比,每天使用20毫克氟西汀的常规治疗并没有减少中风后出现临床显著抑郁症状的人的比例,也没有影响开抗抑郁药或接受非药物治疗的人的比例。

Stroke:替格瑞洛-阿司匹林联用治疗卒中,利大于弊

在轻中度缺血性卒中或高危TIA患者中,使用ticagrelor-aspirin进行30天治疗的缺血益处超过了出血风险。

Stroke : 脑中风后,血压管理,存在种族差异

与有或无卒中的白人成年人相比,黑人控制血压的比例较低,

拓展阅读

【协和医学杂志】卒中后中枢性疼痛的诊断及治疗进展

本文从CPSP的临床特征、流行病学、发病机制及治疗手段等方面展开综述,以期为CPSP的诊断及有效治疗提供参考。

卒中计划早期诊断评分表(ASPECTS评分)

卒中计划早期诊断评分表(ASPECTS评分)

SVN:系统性红斑狼疮患者中风风险的十年跟踪调查

系统性红斑狼疮患者发生持续10年的缺血性中风的风险仍增高,同时由于出血性中风的风险,系统性红斑狼疮患者应谨慎使用抗血小板药物,以预防心血管事件的发生。

European Radiology:聚焦CT血管造影选择性显示卒中相关动脉的技术可行性

现阶段,深度学习彻底改变了图像后处理,并可用于许多医学图像执行任务。

神经科一周速递:热点解读进展大盘点!

一周热点分享 ,紧跟神经科学前沿,让每一次诊疗都更精准,点击立即查看!

Stroke:卒中与癫痫风险—— 一项基于丹麦全国登记的研究

脑卒中后癫痫的绝对和相对风险估计值均低于之前的研究。

脑卒中一级预防的最佳证据总结

暂未更新 · 2024-01-10

成人脑卒中患者久坐行为管理的最佳证据总结

南昌大学护理学院 · 2024-01-10

脑卒中后认知功能障碍危险因素管理的证据总结

广西中医药大学护理学院 · 2023-10-01